Eve A. Olman

643 total citations
8 papers, 532 citations indexed

About

Eve A. Olman is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Eve A. Olman has authored 8 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Eve A. Olman's work include Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Eve A. Olman is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Cancer therapeutics and mechanisms (3 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). Eve A. Olman collaborates with scholars based in United States. Eve A. Olman's co-authors include Merrill J. Egorin, Joseph Aisner, Margaret Whitacre, David A. Van Echo, Stuart J. Tipping, Bruce Thompson, Alan Forrest, D L Trump, Robert S. Witte and Jim M. Koeller and has published in prestigious journals such as Life Sciences, Drug Metabolism and Disposition and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Eve A. Olman

7 papers receiving 517 citations

Peers

Eve A. Olman

ONCOL

PFM

MB

PRM

PPCH

Chabner Ba United States

U. Bruntsch Germany

Ole Hansen Denmark

DavidS. Alberts United States

Hoffmann-La Roche France

Suzanne M. Fields United States

P Cappelaere France

Robert F. Asbury United States

Z. R. Desai United Kingdom

J A Sinkule United States

Chabner Ba United States

Eve A. Olman

238 ×0.8

ONCOL

167 ×0.8

PFM

132 ×0.9

MB

56 ×0.7

PRM

19 ×0.3

PPCH

Citations per year, relative to Eve A. Olman Eve A. Olman (= 1×) peers Chabner Ba

Countries citing papers authored by Eve A. Olman

Since Specialization

Citations

This map shows the geographic impact of Eve A. Olman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eve A. Olman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eve A. Olman more than expected).

Fields of papers citing papers by Eve A. Olman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eve A. Olman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eve A. Olman. The network helps show where Eve A. Olman may publish in the future.

Co-authorship network of co-authors of Eve A. Olman

This figure shows the co-authorship network connecting the top 25 collaborators of Eve A. Olman. A scholar is included among the top collaborators of Eve A. Olman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eve A. Olman. Eve A. Olman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Egorin, Merrill J., David A. Van Echo, Margaret Whitacre, et al.. (1985). Human Pharmacokinetics and Correlation With Clinical Toxicities of the Anthracycline Antibiotic Menogaril (7-Omen). Journal of Bioresource Management. 26. 155. 3 indexed citations

2.

Jones, James M., Eve A. Olman, Merrill J. Egorin, & Joseph Aisner. (1985). A case report and description of the pharmacokinetic behavior of intrapleurally instilled etoposide. Cancer Chemotherapy and Pharmacology. 14(2). 172–174. 19 indexed citations

3.

Egorin, Merrill J., David A. Van Echo, Eve A. Olman, et al.. (1985). Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.. PubMed. 45(12 Pt 1). 6502–6. 155 indexed citations

4.

Trump, D L, et al.. (1985). Phase I study of vinblastine and verapamil given by concurrent iv infusion.. PubMed. 69(7-8). 795–9. 67 indexed citations

5.

Dodion, P., et al.. (1984). The disposition of the new anthracycline antibiotic, menogarol, in mice.. Drug Metabolism and Disposition. 12(3). 365–370. 8 indexed citations

6.

Egorin, Merrill J., David A. Van Echo, Stuart J. Tipping, et al.. (1984). Pharmacokinetics and dosage reduction of cis-diammine(1,1-cyclobutanedicarboxylato)platinum in patients with impaired renal function.. PubMed. 44(11). 5432–8. 258 indexed citations

7.

Chang, Barbara K., et al.. (1984). Fourth NCI - EORTC Symposium on New Drugs in Cancer Therapy Brussels, Belgium December 14–17, 1983. Investigational New Drugs. 2(1). 85–128.

8.

Egorin, Merrill J., et al.. (1983). The plasma pharmacokinetics and tissue distribution of dimethyl sulfoxide in mice. Life Sciences. 33(13). 1223–1230. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact